Align Technology (ALGN) Net Income towards Common Stockholders (2009 - 2026)
Align Technology's (ALGN) quarterly Net Income towards Common Stockholders came in at $112.8 million in Q1 2026, up 20.96% year-on-year from $93.2 million in Q1 2025, and down 16.93% on a QoQ basis from $135.8 million in Q4 2025.
Align Technology (ALGN) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Align Technology (ALGN) has 18 years of Net Income towards Common Stockholders data on file, last reported at $112.8 million in Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders rose 20.96% year-over-year to $112.8 million in Q1 2026; TTM through Mar 2026 was $429.9 million, a 4.97% increase from a year earlier, with the FY2025 full-year figure at $410.4 million, down 2.61% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at $112.8 million, down from $135.8 million in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for ALGN reached as high as $135.8 million in Q4 2025 and fell as low as $41.7 million in Q4 2022.
- Historically, Net Income towards Common Stockholders has averaged $103.0 million across 5 years, with a median of $111.8 million in 2023.
- Across the five-year window, Net Income towards Common Stockholders slumped 78.14% in 2022 and surged 197.13% in 2023, its largest moves.
- Year by year, Net Income towards Common Stockholders stood at $41.7 million in 2022, then jumped by 197.13% to $124.0 million in 2023, then decreased by 16.32% to $103.8 million in 2024, then soared by 30.81% to $135.8 million in 2025, then dropped by 16.93% to $112.8 million in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $112.8 million in Q1 2026, $135.8 million in Q4 2025, and $56.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 22.13 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Baxter International | 12.00 Bn | 9.98 Bn | 891.00 Mn | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 112.77 Mn |
| Dec 31, 2025 | 135.76 Mn |
| Sep 30, 2025 | 56.73 Mn |
| Jun 30, 2025 | 124.61 Mn |
| Mar 31, 2025 | 93.23 Mn |
| Dec 31, 2024 | 103.78 Mn |
| Sep 30, 2024 | 115.93 Mn |
| Jun 30, 2024 | 96.56 Mn |
| Mar 31, 2024 | 105.03 Mn |
| Dec 31, 2023 | 124.01 Mn |
| Sep 30, 2023 | 121.43 Mn |
| Jun 30, 2023 | 111.79 Mn |
| Mar 31, 2023 | 87.82 Mn |
| Dec 31, 2022 | 41.74 Mn |
| Sep 30, 2022 | 72.70 Mn |
| Jun 30, 2022 | 112.81 Mn |
| Mar 31, 2022 | 134.29 Mn |
| Dec 31, 2021 | 190.96 Mn |
| Sep 30, 2021 | 180.99 Mn |
| Jun 30, 2021 | 199.70 Mn |